Boston, MA -- (SBWIRE) -- 12/19/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: Rigel Pharmaceuticals, Inc.(NASDAQ:RIGL), Advanced Cell Technology, Inc.(OTCMKTS:ACTC), MGM Resorts International(NYSE:MGM), Avanir Pharmaceuticals Inc(NASDAQ:AVNR)
Rigel Pharmaceuticals, Inc.(NASDAQ:RIGL) opened its shares at the price of $2.42 for the day. Its closing price was $2.35 after losing -2.08% for the day. The company traded with the total volume of 1.56 million shares, while its average trading volume remained 830,401.00 shares. The beta of RIGL stands at 1.23. Rigel Pharmaceuticals, Inc., a clinical-stage drug development company, discovers and develops novel and small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders.
Has RIGL Found The Bottom and Ready To Move Up? Find Out Here
Advanced Cell Technology, Inc.(OTCMKTS:ACTC) percentage change surged +6.09% to close at $0.0679 with the total traded volume of 6.69 million shares, and average volume of 3.61 million. The 52 week range of the stock remained $0.05 - $0.10, while its day lowest price was $0.06 and it hit its day highest price at $0.07. Advanced Cell Technology, Inc., a biotechnology company, engages in the development and commercialization of human embryonic and adult stem cell technology in the field of regenerative medicine.
For How Long ACTC’s Gloss will Attract Investors ? Find out via this report
MGM Resorts International(NYSE:MGM) started its trading session with the price of $22.33 and closed at $22.65 by scoring +1.94%. MGM’s stocks traded with total volume of 16.65 million shares, while the average trading volume remained 8.51 million shares. The beta of MGM stands at 3.95. Day range of the stock was $22.08 -$22.66. MGM Resorts International, through its wholly owned subsidiaries, owns and/or operates casino resorts.
Will MGM Continue To Move Higher? Find Out Here
Avanir Pharmaceuticals Inc(NASDAQ:AVNR) ended its day with the loss of -1.12% and closed at the price of $2.65 after opening at $2.67. Stock traded during its last trading session with the total volume of 3.78 million shares, as compared to its average volume of 2.54 million shares. Avanir Pharmaceuticals, Inc., together with its subsidiaries, is engaged in acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders primarily in the United States.
Will AVNR Get Buyers Even After The Recent Rally? Find Out Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)